275 related articles for article (PubMed ID: 16311994)
1. Total synthesis, NMR solution structure, and binding model of the potent histone deacetylase inhibitor FR235222.
Rodriquez M; Terracciano S; Cini E; Settembrini G; Bruno I; Bifulco G; Taddei M; Gomez-Paloma L
Angew Chem Int Ed Engl; 2006 Jan; 45(3):423-7. PubMed ID: 16311994
[No Abstract] [Full Text] [Related]
2. Total synthesis of cyclic tetrapeptide FR235222, a potent immunosuppressant that inhibits mammalian histone deacetylases.
Xie W; Zou B; Pei D; Ma D
Org Lett; 2005 Jun; 7(13):2775-7. PubMed ID: 15957944
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of cyclopeptide analogues of the potent histone deacetylase inhibitor FR235222.
Gomez-Paloma L; Bruno I; Cini E; Khochbin S; Rodriquez M; Taddei M; Terracciano S; Sadoul K
ChemMedChem; 2007 Oct; 2(10):1511-9. PubMed ID: 17694590
[TBL] [Abstract][Full Text] [Related]
4. Total synthesis of azumamide A and azumamide E, evaluation as histone deacetylase inhibitors, and design of a more potent analogue.
Wen S; Carey KL; Nakao Y; Fusetani N; Packham G; Ganesan A
Org Lett; 2007 Mar; 9(6):1105-8. PubMed ID: 17311393
[TBL] [Abstract][Full Text] [Related]
5. Molecular modeling studies toward the structural optimization of new cyclopeptide-based HDAC inhibitors modeled on the natural product FR235222.
Di Micco S; Terracciano S; Bruno I; Rodriquez M; Riccio R; Taddei M; Bifulco G
Bioorg Med Chem; 2008 Sep; 16(18):8635-42. PubMed ID: 18715788
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of a potent histone deacetylase inhibitor.
Liu T; Kapustin G; Etzkorn FA
J Med Chem; 2007 May; 50(9):2003-6. PubMed ID: 17419603
[TBL] [Abstract][Full Text] [Related]
7. The first biologically active synthetic analogues of FK228, the depsipeptide histone deacetylase inhibitor.
Yurek-George A; Cecil AR; Mo AH; Wen S; Rogers H; Habens F; Maeda S; Yoshida M; Packham G; Ganesan A
J Med Chem; 2007 Nov; 50(23):5720-6. PubMed ID: 17958342
[TBL] [Abstract][Full Text] [Related]
8. Chlamydocin analogs bearing carbonyl group as possible ligand toward zinc atom in histone deacetylases.
Bhuiyan MP; Kato T; Okauchi T; Nishino N; Maeda S; Nishino TG; Yoshida M
Bioorg Med Chem; 2006 May; 14(10):3438-46. PubMed ID: 16439135
[TBL] [Abstract][Full Text] [Related]
9. Novel histone deacetylase inhibitors: cyclic tetrapeptide with trifluoromethyl and pentafluoroethyl ketones.
Jose B; Oniki Y; Kato T; Nishino N; Sumida Y; Yoshida M
Bioorg Med Chem Lett; 2004 Nov; 14(21):5343-6. PubMed ID: 15454224
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of histone deacetylase inhibitors that are based on FR235222: a cyclic tetrapeptide scaffold.
Singh EK; Ravula S; Pan CM; Pan PS; Vasko RC; Lapera SA; Weerasinghe SV; Pflum MK; McAlpine SR
Bioorg Med Chem Lett; 2008 Apr; 18(8):2549-54. PubMed ID: 18381239
[TBL] [Abstract][Full Text] [Related]
11. Toward an HDAC6 inhibitor: synthesis and conformational analysis of cyclic hexapeptide hydroxamic acid designed from alpha-tubulin sequence.
Jose B; Okamura S; Kato T; Nishino N; Sumida Y; Yoshida M
Bioorg Med Chem; 2004 Mar; 12(6):1351-6. PubMed ID: 15018907
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships of aryloxyalkanoic acid hydroxyamides as potent inhibitors of histone deacetylase.
Marson CM; Mahadevan T; Dines J; Sengmany S; Morrell JM; Alao JP; Joel SP; Vigushin DM; Charles Coombes R
Bioorg Med Chem Lett; 2007 Jan; 17(1):136-41. PubMed ID: 17046252
[TBL] [Abstract][Full Text] [Related]
13. Molecular design of histone deacetylase inhibitors by aromatic ring shifting in chlamydocin framework.
Shivashimpi GM; Amagai S; Kato T; Nishino N; Maeda S; Nishino TG; Yoshida M
Bioorg Med Chem; 2007 Dec; 15(24):7830-9. PubMed ID: 17881232
[TBL] [Abstract][Full Text] [Related]
14. Elucidation of the structure and intermolecular interactions of a reversible cyclic-peptide inhibitor of the proteasome by NMR spectroscopy and molecular modeling.
Stauch B; Simon B; Basile T; Schneider G; Malek NP; Kalesse M; Carlomagno T
Angew Chem Int Ed Engl; 2010 May; 49(23):3934-8. PubMed ID: 20408152
[No Abstract] [Full Text] [Related]
15. Synthesis and histone deacetylase inhibitory activity of cyclic tetrapeptides containing a retrohydroxamate as zinc ligand.
Nishino N; Yoshikawa D; Watanabe LA; Kato T; Jose B; Komatsu Y; Sumida Y; Yoshida M
Bioorg Med Chem Lett; 2004 May; 14(10):2427-31. PubMed ID: 15109626
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activity of cyclotetrapeptide analogues of the natural HDAC inhibitor FR235222.
Terracciano S; Di Micco S; Bifulco G; Gallinari P; Riccio R; Bruno I
Bioorg Med Chem; 2010 May; 18(9):3252-60. PubMed ID: 20381359
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, biological evaluation, and molecular docking of Ugi products containing a zinc-chelating moiety as novel inhibitors of histone deacetylases.
Grolla AA; Podestà V; Chini MG; Di Micco S; Vallario A; Genazzani AA; Canonico PL; Bifulco G; Tron GC; Sorba G; Pirali T
J Med Chem; 2009 May; 52(9):2776-85. PubMed ID: 19344175
[TBL] [Abstract][Full Text] [Related]
18. 2-Trifluoroacetylthiophenes, a novel series of potent and selective class II histone deacetylase inhibitors.
Jones P; Bottomley MJ; Carfí A; Cecchetti O; Ferrigno F; Lo Surdo P; Ontoria JM; Rowley M; Scarpelli R; Schultz-Fademrecht C; Steinkühler C
Bioorg Med Chem Lett; 2008 Jun; 18(11):3456-61. PubMed ID: 18440229
[TBL] [Abstract][Full Text] [Related]
19. Design and campaign synthesis of piperidine- and thiazole-based histone deacetylase inhibitors.
Andrews DM; Stokes ES; Carr GR; Matusiak ZS; Roberts CA; Waring MJ; Brady MC; Chresta CM; East SJ
Bioorg Med Chem Lett; 2008 Apr; 18(8):2580-4. PubMed ID: 18378449
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and evaluation of cyclic amide/imide-bearing hydroxamic acid derivatives as class-selective histone deacetylase (HDAC) inhibitors.
Shinji C; Maeda S; Imai K; Yoshida M; Hashimoto Y; Miyachi H
Bioorg Med Chem; 2006 Nov; 14(22):7625-51. PubMed ID: 16877001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
